Treatments for Depression in Bipolar II Disorder

Am J Psychiatry. 2022 Sep;179(9):688-690. doi: 10.1176/appi.ajp.22010081.

Authors

Suresh Durgam¹, Richard Chen¹, Joseph R Calabrese¹, Gary S Sachs¹

Affiliation

¹ Intra-Cellular Therapies, Inc., New York (Durgam, Chen); Department of Psychiatry, Case Western Reserve School of Medicine, Cleveland, and University Hospitals Cleveland Medical Center, Cleveland (Calabrese); Massachusetts General Hospital, Boston, and Signant Health, Plymouth Meeting, Pa. (Sachs).

PMID: 36048493
DOI: 10.1176/appi.ajp.22010081

No abstract available

Keywords: Antipsychotics; Bipolar II Disorder; Bipolar and Related Disorders; Clinical Drug Studies; Pharmacotherapy; Second Generation.

Publication types

Letter
Comment

MeSH terms

Antipsychotic Agents* / therapeutic use
Benzodiazepines / therapeutic use
Bipolar Disorder* / complications
Bipolar Disorder* / drug therapy
Depression
Humans

Substances

Antipsychotic Agents
Benzodiazepines